Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Shiyu Yin, Ming Huang, Dengju Li, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 51, Iss. 4, pp. 1107-1110
Open Access | Times Cited: 438

Showing 26-50 of 438 citing articles:

Neuromechanisms of SARS-CoV-2: A Review
Marcos F. DosSantos, Sylvie Devalle, Veronica Aran, et al.
Frontiers in Neuroanatomy (2020) Vol. 14
Open Access | Times Cited: 155
COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review
Mariusz Kowalewski, Dario Fina, Artur Słomka, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 151
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
Sophie Susen, Charles Tacquard, Alexandre Godon, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 140
The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
Juan Simón Rico-Mesa, Daniel Rosas, Ashkan Ahmadian-Tehrani, et al.
Current Cardiology Reports (2020) Vol. 22, Iss. 7
Open Access | Times Cited: 139
Use of convalescent plasma in hospitalized patients with COVID-19: case series
Livia Hegerova, Ted Gooley, Kelly A. Sweerus, et al.
Blood (2020) Vol. 136, Iss. 6, pp. 759-762
Open Access | Times Cited: 139
Multiorgan Failure With Emphasis on Acute Kidney Injury and Severity of COVID-19: Systematic Review and Meta-Analysis
Michael Anthonius Lim, Raymond Pranata, Ian Huang, et al.
Canadian Journal of Kidney Health and Disease (2020) Vol. 7, pp. 205435812093857-205435812093857
Open Access | Times Cited: 138
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
Monia Marchetti
Annals of Hematology (2020) Vol. 99, Iss. 8, pp. 1701-1707
Open Access | Times Cited: 131
D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review
Sofia Vidali, Daniele Morosetti, Elsa Cossu, et al.
ERJ Open Research (2020) Vol. 6, Iss. 2, pp. 00260-2020
Open Access | Times Cited: 129
Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
Shir Tal, Galia Spectre, Ran Kornowski, et al.
Acta Haematologica (2020) Vol. 143, Iss. 5, pp. 417-424
Open Access | Times Cited: 126
Coagulopathy in COVID-19: Manifestations and management
Simon Mucha, Siddharth Dugar, Keith R. McCrae, et al.
Cleveland Clinic Journal of Medicine (2020) Vol. 87, Iss. 8, pp. 461-468
Open Access | Times Cited: 122
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
Ivan Mercurio, Vincenzo Tragni, Francesco Busto, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 4, pp. 1501-1522
Open Access | Times Cited: 121
Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic
Robert D. McBane, Victor D. Torres Roldan, Alexander S. Niven, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 11, pp. 2467-2486
Open Access | Times Cited: 120
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19
Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, et al.
Thrombosis Research (2020) Vol. 196, pp. 99-105
Open Access | Times Cited: 117
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation
Emmanuel J. Favaloro, Jecko Thachil
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 58, Iss. 8, pp. 1191-1199
Open Access | Times Cited: 114
Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología
David Vivas, Vanessa Roldán, María Asunción Esteve‐Pastor, et al.
Revista Española de Cardiología (2020) Vol. 73, Iss. 9, pp. 749-757
Open Access | Times Cited: 113
Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction
Anas Hamadeh, Ali Aldujeli, Kasparas Briedis, et al.
The American Journal of Cardiology (2020) Vol. 131, pp. 1-6
Open Access | Times Cited: 108
COVID-19 Related Coagulopathy: A Distinct Entity?
Benjamin Marchandot, Laurent Sattler, Laurence Jesel, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1651-1651
Open Access | Times Cited: 105
Comparison of SARS-CoV-2 infections among 3 species of non-human primates
Shuaiyao Lu, Yuan Zhao, Wenhai Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 99
Cerebral venous thrombosis: Atypical presentation of COVID-19 in the young
David E. Klein, Richard Libman, Claudia Kirsch, et al.
Journal of Stroke and Cerebrovascular Diseases (2020) Vol. 29, Iss. 8, pp. 104989-104989
Open Access | Times Cited: 98
The need to manage the risk of thromboembolism in COVID-19 patients
Inayat Khan, Sugeevan Savarimuthu, Marco Shiu Tsun Leung, et al.
Journal of Vascular Surgery (2020) Vol. 72, Iss. 3, pp. 799-804
Open Access | Times Cited: 97
Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19)
Marcello Ciaccio, Luisa Agnello
Diagnosis (2020) Vol. 7, Iss. 4, pp. 365-372
Open Access | Times Cited: 93
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Upendra Katneni, Aikaterini Alexaki, Ryan Hunt, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 12, pp. 1668-1679
Open Access | Times Cited: 93
Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications
Margarita V. Revzin, Sarah Raza, Robin Warshawsky, et al.
Radiographics (2020) Vol. 40, Iss. 6, pp. 1574-1599
Open Access | Times Cited: 92
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
David Vivas, Vanessa Roldán, María Asunción Esteve‐Pastor, et al.
Revista Española de Cardiología (English Edition) (2020) Vol. 73, Iss. 9, pp. 749-757
Open Access | Times Cited: 91
The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: The Padua province experience
Raffaele Pesavento, Davide Ceccato, Giampaolo Pasquetto, et al.
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 10, pp. 2629-2635
Open Access | Times Cited: 87

Scroll to top